Orelabrutinib combined with short-course bendamustine-rituximab (BR) for first-line treatment of chronic lymphocytic leukemia: A prospective multicenter study
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Linlin Cao, Hao Song, Guolin Wu, Hu Mao Gui, Qiang Xu, CuiCui Wang, Dandan Fan, Yuanyuan Feng, ChenYang Zhou, Jing Ming, Xinchen Wang, Jing Wang, Meiqi Ding, Youzhi Wu, Long Zhong, Kaiyang Ding
Institution: Anqing City Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108664376
Cites:
Cited by:
Related to: